1ERIKSSON P,DEGUCHI H,SAMNERGARD A,et al. Hu man evidence that the cystatin C gene is implicated in focal progression of coronary artery disease [J]. Arterioscler Thromb Vase Biol, 2004,24 : 551-557.
10Eriksson P, Deguchi H, Samnegard A, et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease [J]. Artefioscler Thromb Vasec Biol, 2004, 24(3): 551-7.
4Pessolano LJ, Sullivan CP, Seidl SE, et al. Trafficking of endogenous smooth muscle Cell cholesterol : a role for serum amyloid A and inter-leu- kin-1β[ J ]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2012, 32(11) : 2741-2750.
5Schillinger M, Exner M, Mlekusch W, et al. Inflammation and carotid Artery--Risk for atherosclerosis study ( ICARAS ) [ J ]. Circulation, 2005, 111(17) : 2203-2209.
6Getz GS, Wool GD, Reardon CA. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders [ J ]. Current Pharmaceutical Design, 2010, 16(28) : 3173-3184.
7Jovanovic D, Krstivojevic P, Obradovic I, et al. Serum cystatin Cand beta2-microglobulin as markers of glomerular filtrationrate[J]. Ren Fail, 2003,25 (1) : 123-125.
8Ni L, Lv J, Hou LB, et al. Cystatin C, associated with hemorrhagic and ischemic stroke,is a strong predictor of the risk of cardiovascular events and death in Chinese[J]. Stroke,2007,38(12) :3287-3288.
9Taglieri NK, Ming W, Kaski JC. cystatin C and cardiovaseularrisk[J]. Ann Biol Clin (Paris), 2010, 68 ( 5 ) : 517- 529.
10Xiao D,Liu H,Zhang H,et al. Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke[J]. J Neurol, 2012,259 (10) : 2053-2059.
